Other
E-Cigarette (EC)
E-Cigarette (EC) is an intervention with 3 clinical trials. Currently 2 active trials ongoing. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
OTHER
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
2(67%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_1
1
33%
Ph not_applicable
2
67%
Phase Distribution
1
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution3 total trials
Phase 1Safety & dosage
1(33.3%)
N/ANon-phased studies
2(66.7%)
Highest Phase Reached
Phase 1Trial Status & Enrollment
Completion Rate
100.0%
1 of 1 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
2
trials recruiting
Total Trials
3
all time
Status Distribution
Active(2)
Completed(1)
Detailed Status
Completed1
Active, not recruiting1
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
2
Success Rate
100.0%
Most Advanced
Phase 1
Trials by Phase
Phase 11 (33.3%)
N/A2 (66.7%)
Trials by Status
completed133%
active_not_recruiting133%
recruiting133%
Recent Activity
2 active trials
Showing 3 of 3
active_not_recruitingphase_1
E-cigarette Harm Reduction Among PLWHA in South Africa
NCT06169813
recruitingnot_applicable
E-cigarettes for Harm Reduction Among Smokers With Serious Mental Illness
NCT05815199
completednot_applicable
Electronic Cigarettes as a Harm Reduction Strategy Among Patients With COPD
NCT04465318
Clinical Trials (3)
Showing 3 of 3 trials
NCT06169813Phase 1
E-cigarette Harm Reduction Among PLWHA in South Africa
NCT05815199Not Applicable
E-cigarettes for Harm Reduction Among Smokers With Serious Mental Illness
NCT04465318Not Applicable
Electronic Cigarettes as a Harm Reduction Strategy Among Patients With COPD
All 3 trials loaded
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 3